Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Kent Mark D. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that President - MSO Mark D. Kent received a grant of 87,719 restricted stock units of Common Stock. These units vest in roughly equal one-third installments on March 13, 2027, 2028 and 2029, contingent on continued service, bringing his direct holdings to 102,567 shares.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare EVP Corporate Affairs Joseph S. Konowiecki received a grant of 122,807 restricted stock units of common stock. The award was made at no cash cost to him and is compensation-related rather than an open‑market purchase.
Each restricted stock unit represents one share of Alignment Healthcare common stock. The units will vest in three roughly equal installments on March 13, 2027, March 13, 2028 and March 13, 2029, as long as he continues serving the company on those dates. After this grant, he directly holds 1,203,816 shares of common stock.
Alignment Healthcare, Inc. President - MSO Mark D. Kent reported an open-market purchase of 14,848 shares of Common Stock at $13.31 per share on June 2, 2026. Following this transaction, he directly holds 14,848 shares.
Alignment Healthcare, Inc. filed an initial Form 3 for Shane J. Hochradel, who serves as Chief Operations Officer. This filing establishes him as a reporting person for Alignment Healthcare equity. The submission reports no insider transactions or holdings details in the disclosed data.
Alignment Healthcare, Inc. filed an initial ownership report for executive Mark D. Kent, who serves as President - MSO. This Form 3 filing establishes him as a reporting officer of the company. The filing does not report any transactions or share holdings at this time.
Alignment Healthcare, Inc. President Dawn Christine Maroney reported insider transactions in common stock. She sold 30,000 shares in an open-market sale at a weighted-average price of $16.0855 per share under a Rule 10b5-1 plan adopted on 05/22/25. She also made bona fide gifts totaling 21,500 shares to a family member and a charitable donor advised fund. After these transactions, she directly holds 977,313 shares.
General Atlantic and affiliated entities report shared beneficial ownership of 308,852 shares of Alignment Healthcare, Inc. Class A common stock. The filing states the Reporting Persons may be deemed to beneficially own 308,852 shares, representing 0.1% of the company's 206,733,823 shares outstanding as of April 27, 2026. The ownership is held across multiple General Atlantic entities and the GA Funds; voting and dispositive power are reported as shared.
Alignment Healthcare, Inc. ownership disclosure: Wellington Management affiliates report beneficial ownership of 17,098,936 shares of common stock, representing 8.37% of the class as stated in this Schedule 13G/A (cover shows 03/31/2026). The filing lists shared voting power of 14,895,474 shares and shared dispositive power of 17,098,936 across named Wellington entities. The submission identifies the reporting entities and parent/subsidiary relationships and is signed by a Compliance Manager on behalf of the Wellington filers.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 298,000 shares of common stock on May 11, 2026 through an entity associated with him. The transactions were executed at weighted-average prices of $16.8494 and $17.5350 per share, across ranges from $16.22 to $17.70. According to a footnote, the sold shares are held by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee. Following these sales, an indirect holding entry shows 1,508,641 shares and a separate direct holding entry shows 1,784,868 shares owned after the reported transactions. A footnote also provides the date of a Rule 10b5-1 plan adoption as November 21, 2025.
Alignment Healthcare, Inc. reported governance and leadership changes. On May 6, 2026, its board amended the Amended and Restated Bylaws to formally add the position of Vice Chair of the Board, who presides over board meetings when the Chairman is absent.
Founder and CEO John Kao has been named Chairman of the Board while continuing as CEO, keeping strategic leadership centralized. Former Chairman Joseph Konowiecki becomes Vice Chairman and Executive Vice President of Corporate Affairs, overseeing Human Resources, Legal and Communications. Mark Kent joins as President of the Management Services Organization, and Shane Hochradel becomes Chief Operations Officer, both reporting to Kao.